Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of dupilumab in adults with atopic dermatitis previously enrolled in dupilumab trials
NL-OMON45990Phase 3Active, not recruiting
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Mar 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of dupilumab, sponsored by Regeneron Pharmaceuticals. Started Mar 2016; status: active, not recruiting.
02
Drugs
Beyond the preview
Go deeper on NL-OMON45990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45990.